ALK-Abelló A/S

ALK-Abelló A/S is a Denmark-based global pharmaceutical company specializing in the prevention, diagnosis, and treatment of allergies. It focuses on research-driven solutions, particularly allergy vaccination therapies that address the underlying causes of allergies rather than just symptoms. The company offers a range of products including tablet vaccines, sublingual vaccines, and subcutaneous injections for allergy immunotherapy, as well as emergency treatments for anaphylaxis and diagnostic tools like skin-prick tests using allergen extracts. ALK-Abelló A/S operates worldwide through subsidiaries, production units, and distributors across Europe, North America, and other international markets, serving patients with innovative allergy management options. Founded in 1923 and headquartered in Hørsholm, Denmark, it remains a leader in the allergy sector of the pharmaceutical industry, emphasizing long-term immunotherapy advancements.